Advertisement

Topics

Latest "Nuvelo, Inc." News Stories

07:28 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "Nuvelo, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Nuvelo, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Nuvelo, Inc. for you to read. Along with our medical data and news we also list Nuvelo, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Nuvelo, Inc. Companies for you to search.

Showing "Nuvelo" News Articles, all 3

Thursday 15th March 2018

ARCA biopharma Inc ABIO Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a drug development company that develops genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventr...


Monday 5th March 2018

ARCA biopharma Inc ABIO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a drug development company that develops genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventr...

Wednesday 14th February 2018

ARCA biopharma Inc ABIO Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a drug development company that develops genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventr...



Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks